Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?
作者信息
Mullins Kim
机构信息
University of Cincinnati College of Nursing, Cincinnati, Ohio, and Oncology Hematology Care, Cincinnatti, Ohio.
出版信息
J Adv Pract Oncol. 2015 Jul-Aug;6(4):351-4. Epub 2015 Jul 1.
Abstract
摘要
相似文献
1
Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?早期非小细胞肺癌的立体定向体部放射治疗：何时以及为何是合适的治疗方法？
J Adv Pract Oncol. 2015 Jul-Aug;6(4):351-4. Epub 2015 Jul 1.
2
Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.电视辅助胸腔镜肺叶切除术与立体定向体部放射治疗相比，与临床 I 期肺癌无复发生存率的提高相关。
J Thorac Cardiovasc Surg. 2018 Jan;155(1):395-402. doi: 10.1016/j.jtcvs.2017.07.065. Epub 2017 Aug 16.
3
A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.一项针对 IA 期非小细胞肺癌楔形切除术与立体定向体部放疗的全国性分析。
J Thorac Cardiovasc Surg. 2017 Aug;154(2):675-686.e4. doi: 10.1016/j.jtcvs.2017.02.065. Epub 2017 Apr 4.
4
Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.I期肺癌健康患者的肺叶切除术与立体定向体部放疗对比
J Thorac Cardiovasc Surg. 2016 Jul;152(1):44-54.e9. doi: 10.1016/j.jtcvs.2016.03.060. Epub 2016 Apr 7.
5
Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.加速超分割放疗与立体定向体部放疗治疗Ⅰ期非小细胞肺癌——单机构长期随访经验
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806318. doi: 10.1177/1533033818806318.
6
Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.立体定向体部放射治疗（SBRT）治疗老年早期肺癌。
Semin Oncol. 2018 Aug;45(4):210-219. doi: 10.1053/j.seminoncol.2018.06.002. Epub 2018 Jul 1.
7
Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma.临床 T1-3N0M0 期非小细胞肺癌患者采用诱导化疗联合立体定向体部放疗与序贯立体定向体部放疗联合化疗的疗效和毒性比较。
Clin Transl Oncol. 2017 Dec;19(12):1498-1506. doi: 10.1007/s12094-017-1694-2. Epub 2017 Jun 6.
8
Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).立体定向体部放疗与肺叶切除术治疗可手术的临床ⅠA期肺腺癌：两项临床试验生存结局的比较及倾向评分分析（JCOG1313-A）
Jpn J Clin Oncol. 2016 Aug;46(8):748-53. doi: 10.1093/jjco/hyw058. Epub 2016 May 12.
9
[Stereotactic radiotherapy for non-small cell lung cancer: From concept to clinical reality. 2011 update].
Cancer Radiother. 2011 Oct;15(6-7):522-6. doi: 10.1016/j.canrad.2011.07.241. Epub 2011 Sep 1.
10
Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.基于倾向评分匹配的立体定向体部放疗与手术治疗高龄（≥70 岁）早期非小细胞肺癌患者的结局比较。
Radiat Oncol. 2019 Nov 7;14(1):195. doi: 10.1186/s13014-019-1399-5.
引用本文的文献
1
Local control and survival after stereotactic body radiation therapy of early-stage lung cancer patients in Slovenia.斯洛文尼亚早期肺癌患者立体定向体部放疗的局部控制和生存。
Radiol Oncol. 2023 Jul 26;57(3):389-396. doi: 10.2478/raon-2023-0032. eCollection 2023 Sep 1.
2
Expression of HIF-1α and P-gp in non-small cell lung cancer and the relationship with HPV infection.缺氧诱导因子-1α（HIF-1α）和P-糖蛋白（P-gp）在非小细胞肺癌中的表达及其与HPV感染的关系。
Oncol Lett. 2016 Aug;12(2):1455-1459. doi: 10.3892/ol.2016.4751. Epub 2016 Jun 17.
本文引用的文献
1
Cancer statistics, 2015.癌症统计数据，2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
2
Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.中央型与周围型肺癌立体定向体部放射治疗后的毒性反应：一项倾向评分匹配对分析。
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):124-32. doi: 10.1016/j.ijrobp.2014.08.345. Epub 2014 Oct 18.
3
The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.RSSearch™ 注册表：接受立体定向放射外科和立体定向体部放射治疗的患者的治疗模式和结果研究。
Radiat Oncol. 2013 Nov 25;8:275. doi: 10.1186/1748-717X-8-275.
4
Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.立体定向消融放疗（SABR）治疗非小细胞肺癌。
Semin Respir Crit Care Med. 2013 Dec;34(6):845-54. doi: 10.1055/s-0033-1358554. Epub 2013 Nov 20.
5
The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.立体定向体部放疗治疗不能手术的早期非小细胞肺癌时肿瘤大小对疗效的影响。
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1064-70. doi: 10.1016/j.ijrobp.2013.08.020. Epub 2013 Oct 24.
6
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.立体定向体部放疗的定义：治疗 I 期非小细胞肺癌的原则与实践。
Strahlenther Onkol. 2014 Jan;190(1):26-33. doi: 10.1007/s00066-013-0450-y. Epub 2013 Sep 21.
7
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.立体定向体部放疗治疗 1 期非小细胞肺癌的安全性和有效性：一种治疗模式和结果分析。
J Thorac Oncol. 2013 Aug;8(8):1050-8. doi: 10.1097/JTO.0b013e318293dc45.
8
Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?早期肺癌筛查后的治疗：手术还是立体定向消融放疗？
Lancet Oncol. 2013 Jun;14(7):e270-4. doi: 10.1016/S1470-2045(12)70592-2.
9
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Ⅰ期和Ⅱ期非小细胞肺癌的治疗：肺癌的诊断和管理，第 3 版：美国胸科医师学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e278S-e313S. doi: 10.1378/chest.12-2359.
10
Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies.立体定向体部放射治疗用于原发性和转移性肺恶性肿瘤的治疗。
Surg Oncol Clin N Am. 2013 Jul;22(3):463-81. doi: 10.1016/j.soc.2013.02.011. Epub 2013 Mar 13.
Zotero 插件